https://www.selleckchem.com/products/kn-62.html
SLE/CYC+ women had a greater prevalence of AMH 1.0 ng/mL compared with women without SLE (prevalence ratio (PR) 2.90, 95% CI 1.29 to 6.51). SLE/CYC- women were also slightly more likely to have AMH 1.0 ng/mL (PR 1.62, 95% CI 0.93 to 2.82) than comparison women. Results were similar when considering AMH 25th percentile by age of comparison women. Treatment with CYC is associated with low AMH in African-American women with SLE. SLE itself may also be associated with reduced AMH, but to a lesser extent. Treatment with CYC is asso
Like
Comment
Share
